Pliant Cash from 2010 to 2025
| PLRX Stock | USD 1.58 0.04 2.47% |
Cash | First Reported 2019-03-31 | Previous Quarter 79.6 M | Current Value 71.2 M | Quarterly Volatility 36.5 M |
Check Pliant Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pliant Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 22.1 M, Net Interest Income of 19 M or Interest Income of 22.1 M, as well as many indicators such as Price To Sales Ratio of 636, Dividend Yield of 0.0 or PTB Ratio of 2.75. Pliant financial statements analysis is a perfect complement when working with Pliant Therapeutics Valuation or Volatility modules.
Pliant | Cash |
Latest Pliant Therapeutics' Cash Growth Pattern
Below is the plot of the Cash of Pliant Therapeutics over the last few years. Cash refers to the most liquid asset of Pliant Therapeutics, which is listed under current asset account on Pliant Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Pliant Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Pliant Therapeutics account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Pliant Therapeutics' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pliant Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Pliant Cash Regression Statistics
| Arithmetic Mean | 31,837,274 | |
| Geometric Mean | 15,645,517 | |
| Coefficient Of Variation | 95.36 | |
| Mean Deviation | 27,586,274 | |
| Median | 33,685,000 | |
| Standard Deviation | 30,359,063 | |
| Sample Variance | 921.7T | |
| Range | 81.6M | |
| R-Value | 0.80 | |
| Mean Square Error | 360.1T | |
| R-Squared | 0.64 | |
| Significance | 0.0002 | |
| Slope | 5,082,691 | |
| Total Sum of Squares | 13825.1T |
Pliant Cash History
Other Fundumenentals of Pliant Therapeutics
| Cash And Short Term Investments | ||
| Change In Cash | ||
| Total Cashflows From Investing Activities | ||
| Other Cashflows From Financing Activities |
Pliant Therapeutics Cash component correlations
Click cells to compare fundamentals
About Pliant Therapeutics Financial Statements
Pliant Therapeutics investors use historical fundamental indicators, such as Pliant Therapeutics' Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pliant Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Pliant Stock Analysis
When running Pliant Therapeutics' price analysis, check to measure Pliant Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pliant Therapeutics is operating at the current time. Most of Pliant Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pliant Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pliant Therapeutics' price. Additionally, you may evaluate how the addition of Pliant Therapeutics to your portfolios can decrease your overall portfolio volatility.